Asthma Market
A new research document is added in HTF MI database of 758 pages, titled as ‘Asthma – Pipeline Review, H1 2020’ with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like North America, Europe, Asia Pacific, Latin America, Rest of the World and important players/vendors such as 2A Pharma AB, 3SBio Inc, 4D Pharma Plc etc. The Study will help you gain insights, upcoming trends and influencing growth prospects for forecast period of 2020Access sample report @ https://www.htfmarketreport.com/sample-report/2606797-asthma-pipeline-review
Summary
Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Pipeline Review, H1 2020, provides an overview of the Asthma (Respiratory) pipeline landscape.
Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include family history, overweight, smoking, exposure to exhaust fumes or other types of pollution and exposure to occupational triggers, such as chemicals used in farming, hairdressing and manufacturing. Treatment includes inhaled corticosteroids, leukotriene modifiers, antihistamines and decongestants.
Companies Mentioned in the Report
2A Pharma AB, 3SBio Inc, 4D Pharma Plc, AB Science SA, AbbVie Inc, Abeome Corp, Adamis Pharmaceuticals Corp, Adare Pharmaceuticals Inc, Advagene Biopharma Co Ltd, Aerami Therapeutics, Akeso Biopharma Inc, Algomedix Inc, ALK-Abello AS, Allergan Plc, Amgen Inc, Amphastar Pharmaceuticals Inc, AnGes Inc, Antisense Therapeutics Ltd, Apollo Endosurgery Inc, Apollo Therapeutics LLC, Aquilon Pharmaceuticals SA, Argenx SE, Artax Biopharma Inc, Artizan Biosciences Inc, ASIT Biotech SA, Aslan Pharmaceuticals Ltd, AstraZeneca Plc, Atrapos Therapeutics LLC, Aurigene Discovery Technologies Ltd, AusBio Ltd, Avidin Ltd, Bai Shuo Beijing Pharmaceutical Technology Co Ltd, Bilix Co Ltd, Biocon Ltd, BiOraliX BV, BiosanaPharma BV, Biotec Pharmacon ASA, Boehringer Ingelheim International GmbH, Celltrion Inc, Celon Pharma SA, Chia Tai Tianqing Pharmaceutical Group Co Ltd, Chiesi Farmaceutici SpA, Chronic Airway Therapeutics Ltd, ConMed Biosciences Inc, Crossject SA, CrystalGenomics Inc, CSL Ltd, CSPC Pharmaceutical Group Ltd, Cumberland Pharmaceuticals Inc, Cynata Therapeutics Ltd, Cytokinetics Inc, Daewoong Pharmaceutical Co Ltd, Daiichi Sankyo Co Ltd, Defensin Therapeutics ApS, Dnarx LLC
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2606797-asthma-pipeline-review
Report Highlights
Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Asthma – Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Asthma (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 8, 13, 46, 31, 6, 119, 29 and 9 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 29 and 8 molecules, respectively.
Asthma (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Asthma (Respiratory).
– The pipeline guide reviews pipeline therapeutics for Asthma (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Asthma (Respiratory) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Asthma (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Asthma (Respiratory)
Reasons to Buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Asthma (Respiratory).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Asthma (Respiratory) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/2606797-asthma-pipeline-review
Table of Contents
Introduction
Asthma – Overview
Asthma – Therapeutics Development
Asthma – Therapeutics Assessment
Asthma – Companies Involved in Therapeutics Development
Asthma – Drug Profiles
Asthma – Dormant Projects
Asthma – Discontinued Products
Asthma – Product Development Milestones
….Continued
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=2606797
It’s vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
[email protected]
About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.
This release was published on openPR.
